Afucosylated Antibody Expression Afucosylated Antibody Expression

CHOK1-FUT8 Afucosylated
Antibody Expression

Antibody Production
  • Fut8 Gene Knock-out Cell Line
  • High Yield & Quality
  • Customized Services
Home > Antibody Production > Afucosylated Antibody Expression

Overview

Upgrading The Efficacy of Your Antibodies with Our Powerful Platform.


Afucosylation has proved to significantly enhance antibody-dependent cell-mediated cytotoxicity (ADCC). This antibody modification has opened up a realm of possibilities of upgraded effectiveness of immunotherapies that involve some types of immune effector cells.


Biointron is excited to introduce our newly launched CHOK1- Fut8KO expression platform for afucosylated antibodies. Integrated with our high-throughput recombinant antibody expression capability and cell line development expertise, afucosylated antibodies can be rapidly produced in Biointron to meet your research and industrial needs.

Afucosylated Antibody Expression Overview

Antibodies with high purity and low endotoxin levels!


Knocked out Fut8 cell line is applied in producing afucosylated antibodies. Fut8 is an enzyme that catalyzes the formation of a-1,6 fucosyl glycosidic bonds, and thus the addition of fucose to asparagine-linked N-acetylglucosamine moieties.1


Biointron's fucose-free host cell CHOK1BN-Fut8KO can be used for industrial production after antibody characterization and functional verification. Compared to the unmodified CHOK1BN cell line, the antibody produced by the modified cell line not only achieves afucosylation but also maintains consistency in terms of expression quantity and quality.

Afucosylated Antibody Expression Overview

Highlights

Advanced Gene-Editing Technology

  • Our technology enables efficient Fut8 gene knockouts
  • We guarantee the fucose knockout in host cells

High Yield and Quality

  • Extensive experience in CHO stable cell line development for over 10 years
  • Flexible for large scale afucosylated antibody production
  • High purity & low endotoxin levels

Customized Sequence, Customized Expression

  • Simply provide your customized sequences and we will express your antibodies
  • Fast antibody products delivery

Case Study

  • Case 1: Glycosylation Profiling
    sample C2193xxxx-1
    Deconvoluted mass spectrum of the full molecular weight for sample C2193xxxx-1
    sample C2193xxxx-2
    Deconvoluted mass spectrum of the full molecular weight for sample C2193xxxx-2
  • Case 2: Purity Verification of the Antibody Expressed by CHOK1BN-Fut8KO
    Purity verification of C2193xxxx-1
    Purity verification of C2193xxxx-1
    Purity verification of C2193xxxx-1: CHOK1BN
    Purity verification of C2193xxxx-2
    Purity verification of C2193xxxx-2
    Purity verification of C2193xxxx-2: CHOK1BN-Fut8KO
  • Case 3: Afucosylated antibody ADCC Activity Increase
    ADCC testing results
    ADCC testing results
  • Case 4: Antibody Affinity Measuring
    Y3; B2258xxx2; 1:1 binding
    Y4; B2258xxx2; 1:1 binding
    Y3; B2258xxx3; 1:1 binding
    Y4; B2258xxx3; 1:1 binding
“The newest offering in our service catalog, Biointron’s CHOK1-FUT8 afucosylated antibody expression, is an exciting addition to our capabilities. Heavily researched, afucosylation will improve your antibody efficacy, and my seasoned team of scientists will make sure the end results go above and beyond expectations.”
Xinyi Zhang
Xinyi Zhang
Antibody Production Team

FAQs

References

  • Ma, M., Fu, Y., Zhou, X., Guan, F., Wang, Y., & Li, X. (2019). Functional roles of fucosylated and O-glycosylated cadherins during carcinogenesis and metastasis. Cellular Signalling, 63, 109365. https://doi.org/10.1016/j.cellsig.2019.109365
  • Pereira, N. A., Chan, K. F., Lin, P. C., & Song, Z. (2018). The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity. mAbs, 10(5), 693–711. https://doi.org/10.1080/19420862.2018.1466767
  • Fischer, S., Handrick, R., & Otte, K. (2015). The art of CHO cell engineering: A comprehensive retrospect and future perspectives. Biotechnology Advances, 33(8), 1878-1896. https://doi.org/10.1016/j.biotechadv.2015.10.015
afucosylated-bg

Committed to Top-Quality Products

At Biointron, we are deeply committed to delivering top-quality products that surpass customer expectations. With every product we offer, we promise to provide unmatched quality, reliability, and satisfaction to our valued customers. Your trust in our brand fuels our passion for continuous improvement, ensuring that we consistently deliver nothing but the best.

Services & Products

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.